Harrow (HROW) Current Assets (2010 - 2026)
Harrow's (HROW) quarterly Current Assets came in at $226.4 million in Q1 2026, up 33.53% year-on-year from $169.5 million in Q1 2025, and up 6.91% quarter-over-quarter from $211.8 million in Q4 2025.
Harrow (HROW) Current Assets (2010 - 2026) Analysis & Trends
Harrow's Current Assets history runs 17 years deep, the most recent figure standing at $226.4 million for Q1 2026.
- On a quarterly basis, Current Assets rose 33.53% year-over-year to $226.4 million in Q1 2026; TTM through Mar 2026 was $226.4 million, a 33.53% increase from a year earlier, with the FY2025 full-year figure at $211.8 million, up 11.65% from the prior year.
- Current Assets advanced to $226.4 million in Q1 2026 per HROW's latest filing, from $211.8 million in the prior quarter.
- Across five years, Current Assets topped out at $226.4 million in Q1 2026 and bottomed at $51.7 million in Q1 2023.
- The 5-year median for Current Assets is $139.4 million (2024), against an average of $130.2 million.
- Across the five-year window, Current Assets slumped 30.78% in 2022 and jumped 142.73% in 2024, its largest moves.
- Year by year, Current Assets stood at $118.3 million in 2022, then advanced by 17.95% to $139.5 million in 2023, then surged by 35.97% to $189.7 million in 2024, then rose by 11.65% to $211.8 million in 2025, then gained by 6.91% to $226.4 million in 2026.
- Per Business Quant, the three latest HROW Current Assets figures stand at $226.4 million (Q1 2026), $211.8 million (Q4 2025), and $177.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | 226.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 226.38 Mn |
| Dec 31, 2025 | 211.75 Mn |
| Sep 30, 2025 | 177.60 Mn |
| Jun 30, 2025 | 154.89 Mn |
| Mar 31, 2025 | 169.54 Mn |
| Dec 31, 2024 | 189.65 Mn |
| Sep 30, 2024 | 147.06 Mn |
| Jun 30, 2024 | 139.39 Mn |
| Mar 31, 2024 | 125.46 Mn |
| Dec 31, 2023 | 139.48 Mn |
| Sep 30, 2023 | 110.28 Mn |
| Jun 30, 2023 | 60.30 Mn |
| Mar 31, 2023 | 51.69 Mn |
| Dec 31, 2022 | 118.26 Mn |
| Sep 30, 2022 | 64.07 Mn |
| Jun 30, 2022 | 64.70 Mn |
| Mar 31, 2022 | 62.32 Mn |
| Dec 31, 2021 | 60.66 Mn |
| Sep 30, 2021 | 91.13 Mn |
| Jun 30, 2021 | 93.47 Mn |